![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 25519 |
FusionGeneSummary for OSBPL10_FOS |
![]() |
Fusion gene information | Fusion gene name: OSBPL10_FOS | Fusion gene ID: 25519 | Hgene | Tgene | Gene symbol | OSBPL10 | FOS | Gene ID | 114884 | 2353 |
Gene name | oxysterol binding protein like 10 | Fos proto-oncogene, AP-1 transcription factor subunit | |
Synonyms | ORP10|OSBP9 | AP-1|C-FOS|p55 | |
Cytomap | 3p23 | 14q24.3 | |
Type of gene | protein-coding | protein-coding | |
Description | oxysterol-binding protein-related protein 10ORP-10OSBP-related protein 10 | proto-oncogene c-FosFBJ murine osteosarcoma viral (v-fos) oncogene homolog (oncogene FOS)FBJ murine osteosarcoma viral oncogene homologFos proto-oncogene, AP-1 trancription factor subunitG0/G1 switch regulatory protein 7activator protein 1cellular o | |
Modification date | 20180523 | 20180523 | |
UniProtAcc | Q9BXB5 | P01100 | |
Ensembl transtripts involved in fusion gene | ENST00000396556, ENST00000438237, ENST00000467647, | ENST00000303562, ENST00000554617, ENST00000556324, ENST00000535987, ENST00000555242, ENST00000555686, ENST00000555347, | |
Fusion gene scores | * DoF score | 7 X 5 X 4=140 | 4 X 7 X 2=56 |
# samples | 7 | 7 | |
** MAII score | log2(7/140*10)=-1 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(7/56*10)=0.321928094887362 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
Context | PubMed: OSBPL10 [Title/Abstract] AND FOS [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Tgene | FOS | GO:0007179 | transforming growth factor beta receptor signaling pathway | 9732876 |
Tgene | FOS | GO:0034614 | cellular response to reactive oxygen species | 17217916 |
Tgene | FOS | GO:0045893 | positive regulation of transcription, DNA-templated | 9732876 |
Tgene | FOS | GO:0045944 | positive regulation of transcription by RNA polymerase II | 10508860 |
Tgene | FOS | GO:0060395 | SMAD protein signal transduction | 9732876 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChiTaRS3.1 | AW939698 | OSBPL10 | chr3 | 31871532 | - | FOS | chr14 | 75748373 | + |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5CDS-3UTR | ENST00000396556 | ENST00000303562 | OSBPL10 | chr3 | 31871532 | - | FOS | chr14 | 75748373 | + |
5CDS-intron | ENST00000396556 | ENST00000554617 | OSBPL10 | chr3 | 31871532 | - | FOS | chr14 | 75748373 | + |
5CDS-intron | ENST00000396556 | ENST00000556324 | OSBPL10 | chr3 | 31871532 | - | FOS | chr14 | 75748373 | + |
5CDS-intron | ENST00000396556 | ENST00000535987 | OSBPL10 | chr3 | 31871532 | - | FOS | chr14 | 75748373 | + |
5CDS-intron | ENST00000396556 | ENST00000555242 | OSBPL10 | chr3 | 31871532 | - | FOS | chr14 | 75748373 | + |
5CDS-3UTR | ENST00000396556 | ENST00000555686 | OSBPL10 | chr3 | 31871532 | - | FOS | chr14 | 75748373 | + |
5CDS-intron | ENST00000396556 | ENST00000555347 | OSBPL10 | chr3 | 31871532 | - | FOS | chr14 | 75748373 | + |
intron-3UTR | ENST00000438237 | ENST00000303562 | OSBPL10 | chr3 | 31871532 | - | FOS | chr14 | 75748373 | + |
intron-intron | ENST00000438237 | ENST00000554617 | OSBPL10 | chr3 | 31871532 | - | FOS | chr14 | 75748373 | + |
intron-intron | ENST00000438237 | ENST00000556324 | OSBPL10 | chr3 | 31871532 | - | FOS | chr14 | 75748373 | + |
intron-intron | ENST00000438237 | ENST00000535987 | OSBPL10 | chr3 | 31871532 | - | FOS | chr14 | 75748373 | + |
intron-intron | ENST00000438237 | ENST00000555242 | OSBPL10 | chr3 | 31871532 | - | FOS | chr14 | 75748373 | + |
intron-3UTR | ENST00000438237 | ENST00000555686 | OSBPL10 | chr3 | 31871532 | - | FOS | chr14 | 75748373 | + |
intron-intron | ENST00000438237 | ENST00000555347 | OSBPL10 | chr3 | 31871532 | - | FOS | chr14 | 75748373 | + |
5UTR-3UTR | ENST00000467647 | ENST00000303562 | OSBPL10 | chr3 | 31871532 | - | FOS | chr14 | 75748373 | + |
5UTR-intron | ENST00000467647 | ENST00000554617 | OSBPL10 | chr3 | 31871532 | - | FOS | chr14 | 75748373 | + |
5UTR-intron | ENST00000467647 | ENST00000556324 | OSBPL10 | chr3 | 31871532 | - | FOS | chr14 | 75748373 | + |
5UTR-intron | ENST00000467647 | ENST00000535987 | OSBPL10 | chr3 | 31871532 | - | FOS | chr14 | 75748373 | + |
5UTR-intron | ENST00000467647 | ENST00000555242 | OSBPL10 | chr3 | 31871532 | - | FOS | chr14 | 75748373 | + |
5UTR-3UTR | ENST00000467647 | ENST00000555686 | OSBPL10 | chr3 | 31871532 | - | FOS | chr14 | 75748373 | + |
5UTR-intron | ENST00000467647 | ENST00000555347 | OSBPL10 | chr3 | 31871532 | - | FOS | chr14 | 75748373 | + |
Top |
FusionProtFeatures for OSBPL10_FOS |
![]() |
Hgene | Tgene |
OSBPL10 | FOS |
Probable lipid transporter involved in lipidcountertransport between the endoplasmic reticulum and the plasmamembrane. Its ability to bind phosphatidylserine, suggests that itspecifically exchanges phosphatidylserine withphosphatidylinositol 4-phosphate (PI4P), deliveringphosphatidylserine to the plasma membrane in exchange for PI4P(PubMed:23934110) (Probable). Plays a role in negative regulationof lipid biosynthesis (PubMed:19554302). Negatively regulates APOBsecretion from hepatocytes (PubMed:19554302, PubMed:22906437).Binds cholesterol and acidic phospholipids (PubMed:22906437). Alsobinds 25-hydroxycholesterol (PubMed:17428193). Bindsphosphatidylserine (PubMed:23934110).{ECO:0000269|PubMed:17428193, ECO:0000269|PubMed:19554302,ECO:0000269|PubMed:22906437, ECO:0000269|PubMed:23934110,ECO:0000305}. | Nuclear phosphoprotein which forms a tight but non-covalently linked complex with the JUN/AP-1 transcription factor.In the heterodimer, FOS and JUN/AP-1 basic regions each seems tointeract with symmetrical DNA half sites. On TGF-beta activation,forms a multimeric SMAD3/SMAD4/JUN/FOS complex at the AP1/SMAD-binding site to regulate TGF-beta-mediated signaling. Has acritical function in regulating the development of cells destinedto form and maintain the skeleton. It is thought to have animportant role in signal transduction, cell proliferation anddifferentiation. In growing cells, activates phospholipidsynthesis, possibly by activating CDS1 and PI4K2A. This activityrequires Tyr-dephosphorylation and association with theendoplasmic reticulum. {ECO:0000269|PubMed:16055710,ECO:0000269|PubMed:17160021, ECO:0000269|PubMed:22105363,ECO:0000269|PubMed:7588633, ECO:0000269|PubMed:9732876}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for OSBPL10_FOS |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for OSBPL10_FOS |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for OSBPL10_FOS |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Tgene | FOS | P01100 | DB08813 | Nadroparin | Proto-oncogene c-Fos | small molecule | approved|investigational |
Top |
RelatedDiseases for OSBPL10_FOS |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Tgene | FOS | C0036572 | Seizures | 4 | CTD_human |
Tgene | FOS | C0038220 | Status Epilepticus | 4 | CTD_human |
Tgene | FOS | C0038587 | Substance Withdrawal Syndrome | 3 | CTD_human |
Tgene | FOS | C0236736 | Cocaine-Related Disorders | 3 | CTD_human |
Tgene | FOS | C0020538 | Hypertensive disease | 2 | CTD_human |
Tgene | FOS | C0003469 | Anxiety Disorders | 1 | CTD_human |
Tgene | FOS | C0011570 | Mental Depression | 1 | PSYGENET |
Tgene | FOS | C0011581 | Depressive disorder | 1 | PSYGENET |
Tgene | FOS | C0014175 | Endometriosis | 1 | CTD_human |
Tgene | FOS | C0014544 | Epilepsy | 1 | CTD_human |
Tgene | FOS | C0016063 | Osteitis Fibrosa Disseminata | 1 | CTD_human |
Tgene | FOS | C0018843 | Heat Stroke | 1 | CTD_human |
Tgene | FOS | C0019080 | Hemorrhage | 1 | CTD_human |
Tgene | FOS | C0020429 | Hyperalgesia | 1 | CTD_human |
Tgene | FOS | C0023893 | Liver Cirrhosis, Experimental | 1 | CTD_human |
Tgene | FOS | C0024121 | Lung Neoplasms | 1 | CTD_human |
Tgene | FOS | C0027765 | nervous system disorder | 1 | CTD_human |
Tgene | FOS | C0035126 | Reperfusion Injury | 1 | CTD_human |
Tgene | FOS | C0040997 | Trigeminal Neuralgia | 1 | CTD_human |
Tgene | FOS | C0041696 | Unipolar Depression | 1 | PSYGENET |
Tgene | FOS | C0235032 | Neurotoxicity Syndromes | 1 | CTD_human |
Tgene | FOS | C0236733 | Amphetamine-Related Disorders | 1 | CTD_human |
Tgene | FOS | C0270458 | Severe major depression with psychotic features | 1 | PSYGENET |
Tgene | FOS | C0424295 | Hyperactive behavior | 1 | CTD_human |
Tgene | FOS | C0740392 | Infarction, Middle Cerebral Artery | 1 | CTD_human |
Tgene | FOS | C0743072 | Depression, psychotic | 1 | PSYGENET |
Tgene | FOS | C1269683 | Major Depressive Disorder | 1 | PSYGENET |
Tgene | FOS | C1458155 | Mammary Neoplasms | 1 | CTD_human |
Tgene | FOS | C1862939 | AMYOTROPHIC LATERAL SCLEROSIS 1 | 1 | CTD_human |
Tgene | FOS | C2239176 | Liver carcinoma | 1 | CTD_human |
Tgene | FOS | C3495559 | Juvenile arthritis | 1 | CTD_human |